Highlights and Quick Summary
- Capex per Share for the quarter ending September 30, 2023 was -0.0 (a 52.38% increase compared to previous quarter)
- Year-over-year quarterly Capex per Share decreased by -34.69%
- Annual Capex per Share for 2022 was -0.18 (a -76.94% decrease from previous year)
- Annual Capex per Share for 2021 was -0.77 (a 446.61% increase from previous year)
- Annual Capex per Share for 2020 was -0.14 (a 95.67% increase from previous year)
- Twelve month Capex per Share ending September 30, 2023 was -0.01 (a -79.97% decrease compared to previous quarter)
- Twelve month trailing Capex per Share decreased by -92.92% year-over-year
Trailing Capex per Share for the last four month:
30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
---|---|---|---|
-0.01 | -0.06 | -0.1 | -0.18 |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex per Share of Absci Corporation
Most recent Capex per Shareof ABSI including historical data for past 10 years.Interactive Chart of Capex per Share of Absci Corporation
Absci Corporation Capex per Share for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | -0.0 | -0.0 | -0.0 | – | – |
2022 | -0.0 | -0.05 | -0.04 | -0.08 | -0.18 |
2021 | -0.17 | -0.08 | -1.01 | -0.37 | -0.77 |
2020 | -0.06 | -0.05 | -0.02 | -0.01 | -0.14 |
2019 | 0.0 | – | – | – | -0.07 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology